8888 J. Am. Chem. Soc., Vol. 122, No. 37, 2000
Lu¨cking et al.
achieved.27 Electrospray ionization (ESI) mass spectra were recorded
on an API III Perkin-Elmer SCIEX triple quadrupole mass spectrometer.
Silica gel chromatography was performed with silica gel 60 (EM
Science or Bodman, 230-400 mesh). All experiments with moisture-
or air-sensitive compounds were performed in anhydrous solvents under
a nitrogen atmosphere.
154.66, 154.1, 149.8, 149.6, 149.4, 138.6, 137.8, 136.5, 135.6, 135.4,
134.9, 128.1, 124.3, 123.7, 121.6, 121.2, 120.4, 120.3, 116.4, 115.9,
33.4, 33.3, 33.0, 32.4, 32.1, 31.9, 30.8, 30.2, 29.8, 29.7, 29.6, 29.4,
28.0, 27.9, 22.7, 14.1, 10.4, 9.8; FTIR (CH2
Cl , cm-1) ν 3409, 3249,
2
2927, 2854, 1666, 1599, 1540, 1514, 1483, 1070, 898, 733, 710; ESI-
MS m/z 1919 ([M + H]+, calcd for C114H148N8O18H 1918).
Diamino Hexaamide Cavitand (7b). Dinitro cavitand 7a (57 mg,
29.8 µmol) was dissolved in a mixture of toluene (15 mL) and EtOH
(2 mL). A catalytic amount of commercial Raney nickel that had been
previously washed with EtOH (3 × 10 mL) was added. The resulting
suspension was evacuated and the reaction flask was filled with H2.
This operation was repeated five times and the mixture was stirred at
40 °C under a H2 atmosphere for 20 h. After cooling, the Raney nickel
was filtered off in a vacuum through a pad of Celite, followed by rinsing
with toluene and EtOH. The filtrates were combined and evaporated
under reduced pressure to give diamine 7b as a yellowish solid (52
mg, 28.1 µmol, 94%) which was taken to the next step without further
purification.
Molecular modeling was performed using the Amber* force field
in the MacroModel 5.5 and 6.5 program.28 Molecular volumes were
calculated with the GRASP program.29
Hexaamide Cavitand (6). Hexanitro cavitand 59 (400 mg, 0.25
mmol) was dissolved in a mixture of toluene (60 mL) and MeOH (20
mL). To this solution was added a catalytic amount of commercial
Raney nickel that had been previously washed with MeOH (2 × 5
mL). The resulting suspension was evacuated and the reaction flask
was filled with H2. This operation was repeated three times and the
mixture was stirred for 12 h at 40 °C under a H2 atmosphere. After
cooling, the Raney nickel was filtered off in a vacuum through a pad
of Celite and rinsed with toluene (50 mL) and MeOH (2 × 50 mL).
The filtrates were combined and evaporated under vacuum to give the
hexaamino cavitand as a brown solid (355 mg, 0.25 mmol, 100%) that
was taken to the next step without further purification. The hexaamino
cavitand (355 mg, 0.25 mmol) was dissolved in degassed CH2Cl2 (20
mL) and kept under N2. Pyridine (380 µL, 4.7 mmol) was added and
the mixture was cooled to -78 °C. Propionyl chloride (204 µL, 2.4
mmol) was added slowly and the resulting solution was kept at -78
°C for 1 h. The reaction was then allowed to slowly warm to room
temperature. After 14 h, the reaction mixture was diluted with CH2Cl2
(30 mL) and washed with 1 N HCl (50 mL) and brine (50 mL). After
drying, the organic layer was concentrated to give a residue (417 mg)
that consisted of a mixture of acylated products. This residue was then
was dissolved in a 1:1 v/v toluene/EtOH mixture (20 mL) and to that
was added NH2NH2-H2O (120 µL, 2.5 mmol). The mixture was stirred
at 85 °C for 4.5 h, after which it was concentrated in a vacuum and
chromatographed in silica gel, eluting with a 98:2 v/v CH2Cl2/MeOH
mixture. The product 6 was obtained as a yellow solid after trituration
with MeOH (55 mg, 31.0 µmol, 13%). Alternatively, hexaamide 6 was
prepared in 66% yield by acylation of the corresponding hexaamino
cavitand with propionyl chloride and K2CO3 in EtOAc/water, 1:1, and
Molecular Container (2). To a solution of 7b from the previous
experiment, was added terephthaldicarboxaldehyde (3.7 mg, 27.6 µmol)
in nitrobenzene (1 mL), the resulting solution was evacuated, and the
reaction flask was filled with N2. The reaction mixture was stirred at
140 °C for 30 h. The solvent was removed under reduced pressure and
the residue was purified by column chromatography (hexane/EtOAc,
4:1-2:1-1:1) to afford product 2 as a white solid (28 mg, 7.4 µmol,
1
52%). H NMR (toluene-d8/2% DMF-d7/2% TFA, 295 K) δ 10.07 (s,
4 H), 9.87 (s, 4 H), 9.43 (s, 4 H), 8.09 (s, 4 H), 7.87 (s, 4 H), 7.82 (s,
4 H), 7.73 (s, 4 H), 7.63 (s, 4 H), 7.52-7.44 (m, 6 H), 7.37 (s, 4 H),
7.22 (s, 4 H), 6.29 (t, J ) 7.8 Hz, 4 H), 6.13-6.05 (m, 4 H), 2.80-
2.00 (m, 40 H), 1.70-1.20 (m, 144 H), 1.1-0.75 (m, 60 H); FTIR
(toluene-d8, cm-1) ν 3617, 3244, 3186, 1660, 1608, 1508, 1479, 1402,
1269, 1221, 1154, 891; MALDI-MS m/z 3812 avg. ([M + H]+, calcd
for C236H302N16O28H 3812).
Molecular Container (3). The crude diamine 7b (17 mg, 9.2 µmol)
was dissolved in THF (2 mL) under a N2 atmosphere. 1,2,5,6-
Tetraketopyracene 830 (1.1 mg, 4.6 µmol) and glacial HOAc (20 µL)
were sequentially added, and the mixture was stirred under reflux for
12 h. After cooling, the solvent was evaporated and the residue was
chromatographed on a preparative thin-layer chromatography plate
(silica gel, 0.5 mm) eluting with a 98:2 v/v mixture of CH2Cl2/MeOH.
Two bands that correspond to the C and the S isomers were isolated
(less polar band ) 5.6 mg, more polar band ) 4.3 mg; combined yield
9.9 mg, 2.55 µmol, 55%). Compound 3 (C-isomer): mp > 250 °C; 1H
NMR (toluene-d8, 295 K) δ 11.08 (s, 1 H, NH), 10.21 (s, 1 H, NH),
10.14 (s, 1 H, NH), 9.91 (s, 1 H, NH), 9.76 (s, 1 H, NH), 9.09 (s, 1 H,
NH), 8.81 (s, 1 H, NH), 8.66 (s, 1 H, NH), 8.25 (s, 1 H, NH), 8.00 (s,
1 H, NH), 7.96-7.57 (m, 14 H), 7.33-6.79 (m, 24 H), 6.49 (m, 2 H,
CH), 6.33 (m, 2 H, CH), 6.19 (m, 2 H, CH), 6.11 (m, 2 H, CH), 2.75-
2.35 (m, 24 H), 2.29-1.88 (m, 16 H), 1.79-1.21 (m, 144 H), 1.06-
0.91 (m, 60 H); FTIR (0.5 mM in toluene-d8, cm-1) ν 3244, 3180,
2926, 2854, 1664, 1512, 1483, 1330, 1275, 1229, 1183, 936, 717;
MALDI-MS m/z 3882 avg. ([M + H]+, calcd for C242H300N16O28H
3882.2).
1
then O-deacylated. Mp > 250 °C; H NMR (benzene-d6, 330 K) δ
9.90 (br, 4 H), 7.68 (s, 2 H), 7.60 (s, 3 H), 7.46 (br, 1 H), 7.35 (s, 2
H), 6.98 (br, 2 H), 6.26 (t, J ) 8 Hz, 3 H), 4.57 (br, 1 H), 2.46-2.36
(m, 20 H), 1.57-1.24 (m, 90 H), 0.97-0.93 (m, 12 H); FTIR (benzene-
d6, cm-1) ν 3246, 2926, 2854, 1665, 1601, 1514, 1485, 1402, 1277,
1224, 937, 896; HRMS-MALDI-FTMS m/z 1776.1020 ([M + Na]+,
calcd for C108H148N6O14Na 1776.0951).
Dinitro Hexaamide Cavitand (7a). A solution of hexaamide 6 (53
mg, 30.3 µmol), 1,2-difluorodinitrobenzene (12 mg, 58.8 µmol), and
Et3N (42 µL, 0.30 mmol) in anhydrous DMF (10 mL) was stirred under
N2 for 15 h at 70 °C. The reaction mixture was cooled, and the volatiles
were removed under vacuum. The residue was chromatographed on
silica gel eluting with a 99:1 v/v mixture of CH2Cl2/MeOH. The dinitro
product was obtained as a yellow solid after trituration with MeOH
1
(38 mg, 19.8 µmol, 65%). Mp > 250 °C; H NMR (benzene-d6, 295
Cavitand (9). A solution of diamine 7b (34 mg, 18.4 µmol) and
terephthaldicarboxaldehyde (2.6 mg, 19.3 µmol) in nitrobenzene (1 mL)
was evacuated and the reaction flask was filled with N2. The reaction
mixture was stirred at 140 °C for 24 h. The solvent was removed under
vacuum and the residue was purified by column chromatography
(hexane/EtOAc, 4:1-2:1-1:1) to afford the product as a white solid
(24 mg, 12.2 µmol, 66%). 1H NMR (CDCl3, 295 K) δ 12.04 (s, 1 H),
10.06 (s, 1 H), 10.03 (s, 1 H), 9.74 (s, 1 H), 9.30 (s, 1 H), 9.14 (s, 1
H), 8.86 (s, 1 H), 8.23 (s, 1 H), 7.95-7.84 (m, 5 H), 7.75 (s, 1 H),
7.70 (s, 1 H), 7.63 (s, 1 H), 7.58 (s, 1 H), 7.45 (s, 1 H), 7.44 (s, 1 H),
7.35 (s, 1 H), 7.34 (s, 1 H), 7.31-7.24 (m, 3 H), 7.22 (s, 1 H), 7.21-
7.15 (m, 3 H), 5.76 (t, J ) 8.2 Hz, 1 H), 5.73-5.61 (m, 3 H), 2.75-
1.75 (m, 20 H), 1.50-1.10 (m, 90 H), 0.98-0.85 (m, 12 H); FTIR
(toluene-d8, cm-1) ν 3234, 3186, 2928, 2851, 1703, 1665, 1608, 1512,
1484, 1407, 1269, 891; ESI-MS m/z 1972 ([M + H]+, calcd for
K) δ 9.74 (s, 2 H), 9.70 (s, 1 H), 8.79 (s, 2 H), 7.93 (s, 2 H), 7.89 (s,
2 H), 7.86 (s, 2 H), 7.77 (s, 2 H), 7.53 (s, 2 H), 7.40 (s, 2 H), 7.31 (s,
2 H), 6.42 (t, J ) 8 Hz, 2 H), 6.17 (t, J ) 8 Hz, 1 H), 5.94 (t, J ) 8
Hz, 1 H), 2.49-2.05 (m, 20 H), 1.47-1.33 (m, 72 H), 1.22-0.93 (m,
30 H); 1H NMR (CDCl3, 295 K) δ 9.46 (s, 2 H), 9.32 (s, 2 H), 8.16 (s,
4 H), 7.69 (s, 2 H), 7.55 (s, 4 H), 7.36 (s, 2 H), 7.30 (s, 4 H), 7.27 (s,
2 H), 5.83-5.78 (m, 3 H), 5.60 (t, J ) 8 Hz, 1 H), 2.57-2.40 (m, 12
H), 2.30-2.21 (m, 8 H), 1.49-1.17 (m, 90 H), 0.92 (t, J ) 7 Hz, 12
H); 13C NMR (CDCl3, 295 K) δ 173.57, 173.56, 173.55, 155.5, 154.70,
(27) For details on high-resolution mass spectrometry, see: (a) Rose,
M. E.; Johnstone, R. A. W. Mass Spectrometry for Chemists and
Biochemists; Cambridge University Press: Cambridge, 1982. (b) Jennings,
K. R.; Dolnikowsi, G. G. Methods in Enzymology; McCloskey, J. A., Ed.;
Academic Press: New York, 1990; p 37 and references therein.
(28) Mohamadi, F.; Richards, N. G.; Guida, W. C.; Liskamp, R.; Lipton,
M.; Caufield, C.; Chang, G.; Hendrickson, T.; Still, W. C. J. Comput. Chem.
1990, 11, 440-467.
C122H154N8O15H 1972).
(29) (a) Nicholls, A.; Sharp, K. A.; Honig, B. Proteins 1991, 11, 281-
296. (b) Mecozzi, S.; Rebek, J., Jr. Chem. Eur. J. 1998, 4, 1016-1022.
(30) Clayton, M. D.; Marcinow, Z.; Rabideau, P. W. Tetrahedron Lett.
1998, 39, 9127-9130.